Skip to main content
Clinical Trials/NCT03510507
NCT03510507UnknownNot Applicable

Characteristics of Positive Lyme PCR Arthritis, Data From CNR Borrelia 2011-2016

University Hospital, Strasbourg, France1 site in 1 country38 target enrollmentStarted: January 20, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
38
Locations
1
Primary Endpoint
Retrospective study of clinical and biological data of French patients with Lyme arthritis between 2011 and 2016

Study Overview

Brief Summary

Lyme disease is due to Borrelia burgdorferi sensu lato and is transmitted by a tick vector of the genus Ixodes. One of the clinical forms of this disease in the disseminated phase is the appearance of arthritis, classically mono or oligo-arthritis in the large joints.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age >18 years
  • Diagnosis of Lyme arthritis confirmed by PCR of joint fluid at CNR Borrelia between 2011 and 2016
  • Patient who has agreed to use his medical data for research purposes

Exclusion Criteria

  • Refusal to participate in the study

Outcomes

Primary Outcomes

Retrospective study of clinical and biological data of French patients with Lyme arthritis between 2011 and 2016

Time Frame: The period from 2011 to 2016 will be examined

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
University Hospital, Strasbourg, France
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials